Article
Siglec10 as an Immunosuppressive and Tumorgenesis Signature for Prediction of Survival Prognosis in Gliomas
2020-07-14
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>Glioma is a type of tumor occurring in central nervous system. Specific factors mutations and molecular abnormalities are used to conduct glioma classification and clinical decision in recent decade. Siglec10 is a member of sialic acid binding immunoglobulin superfamily. <bold>Methods</bold>We analyzed the siglec10 expression in glioma patients with immunohistoche...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9f496d81-37a5-5351-a8e8-1541c72cf93f
- DOI
- 10.21203/rs.3.rs-40997/v1